Henry J. Fuchs
2021
Compensation breakdown
| Non-Equity Incentive Plan | $755,600 |
|---|---|
| Option Awards | $1,202,572 |
| Salary | $750,000 |
| Stock Awards | $4,202,276 |
| Other | $18,918 |
| Total | $6,929,366 |
Fuchs received $4.2M in stock awards, accounting for 61% of the total pay in 2021.
Fuchs also received $755.6K in non-equity incentive plan, $1.2M in option awards, $750K in salary and $18.9K in other compensation.
Rankings
In 2021, Henry J. Fuchs' compensation ranked 1,778th out of 12,405 executives tracked by ExecPay. In other words, Fuchs earned more than 85.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,778 out of 12,405 | 86th |
Division Manufacturing | 657 out of 5,494 | 88th |
Major group Chemicals And Allied Products | 244 out of 2,369 | 90th |
Industry group Drugs | 206 out of 2,090 | 90th |
Industry Pharmaceutical Preparations | 140 out of 1,537 | 91st |
Pay ratio
| Henry J. Fuchs' Pay | $6,929,366 |
|---|---|
| Median Employee's Pay | $175,523 |
| Pay Ratio | 39to 1 |
In 2021, the annual total compensation of Henry J. Fuchs was $6,929,366.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $175,523.
The ratio of Henry J. Fuchs' pay to the pay of median employee was therefore 39 to one.
Fuchs' colleagues
We found four more compensation records of executives who worked with Henry J. Fuchs at BioMarin Pharmaceutical in 2021.
2021
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2021
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2021
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2021
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019